Facebook
Twitter
Telegram
Report an ErrorIGM Biosciences Financial Statements 2011-2024 | IGMS
Annual Financial Statements IGM Biosciences
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap |
640 M | 654 M | 558 M | 2.69 B | 319 M | - | - | - | - | - | - | - | - |
Shares |
52.3 M | 41.5 M | 33.5 M | 30.7 M | 9 M | - | - | - | - | - | - | - | - |
Historical Prices |
12.2 | 15.8 | 16.7 | 87.4 | 51.4 | - | - | - | - | - | - | - | - |
Net Income |
-246 M | -221 M | -165 M | -81.4 M | -43.1 M | -22.7 M | -11.1 M | - | - | - | - | - | - |
Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Cost of Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income |
-263 M | -228 M | -165 M | -83.3 M | -44.5 M | -22.8 M | -11.1 M | - | - | - | - | - | - |
Interest Expense |
-20 K | -181 K | - | - | - | - | - | - | - | - | - | - | - |
EBITDA |
-255 M | -222 M | -161 M | -82.3 M | -43.9 M | -22.5 M | -11 M | - | - | - | - | - | - |
Operating Expenses |
266 M | 229 M | 165 M | 83.3 M | 44.5 M | - | - | - | - | - | - | - | - |
General and Administrative Expenses |
50.1 M | 49.7 M | 38.3 M | 18.2 M | 9.24 M | 3.83 M | 2.51 M | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Income Statement IGM Biosciences
| 2024-Q1 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Shares |
60.1 M | 59.6 M | 45.1 M | 44.5 M | - | 44 M | 43.9 M | 33.8 M | - | 33.4 M | 33.4 M | 33.3 M | 31.3 M | 30.6 M | 30.6 M | 30.5 M | 30.5 M | 4.22 M | 560 K | 443 K | 438 K | 438 K | 438 K | 438 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Net Income |
-49.8 M | -62 M | -64.4 M | -59.3 M | - | -58 M | -58.6 M | -51.9 M | - | -44.2 M | -38.7 M | -31.6 M | -24.6 M | -20.3 M | -18.8 M | -17.6 M | -14.8 M | -10.2 M | -10.7 M | -7.47 M | -9.05 M | -6.52 M | -4.22 M | -2.93 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cost of Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income |
-53.9 M | -66.8 M | -68.2 M | -63.4 M | - | -60.5 M | -59.2 M | -52 M | - | -44.2 M | -38.7 M | -31.7 M | -24.7 M | -20.6 M | -19.4 M | -18.6 M | -15.9 M | -10.7 M | -10.5 M | -7.36 M | -9.05 M | -6.54 M | -4.24 M | -2.96 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Interest Expense |
- | - | - | -20 K | - | - | -131 K | 8 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA |
-51.7 M | - | - | -61.7 M | - | -56.3 M | -56.6 M | -50.7 M | - | -41 M | -36.7 M | -31 M | -24.7 M | -20.4 M | -19.2 M | -18.4 M | -15.9 M | -10.5 M | -10.4 M | -7.24 M | -9.05 M | -6.44 M | -4.24 M | -2.96 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Expenses |
54.4 M | 67.3 M | 68.7 M | 63.9 M | - | 60.8 M | 59.6 M | 52 M | - | 44.2 M | 38.7 M | 31.7 M | 24.7 M | 20.6 M | 19.4 M | 18.6 M | 15.9 M | 10.7 M | 10.5 M | 7.36 M | 9.05 M | 6.54 M | 4.24 M | 2.96 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
General and Administrative Expenses |
10.5 M | 12.5 M | 13 M | 13 M | - | 12.7 M | 12.4 M | 13.1 M | - | 10 M | 8.65 M | 8.13 M | 5.14 M | 4.73 M | 4.39 M | 3.99 M | 3.17 M | 2.39 M | 2.23 M | 1.44 M | 1.23 M | 1.37 M | 794 K | 430 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency